Clinical Trial Update: A Phase II Study of E7389 in Patients With Breast Cancer, Previously Treated With Anthracycline, Taxane and Capecitabine [Phase 2]

View source ↗

Summary

This document reports the results of a Phase II trial of E7389 (eribulin) in patients with breast cancer previously treated with anthracycline, taxane, and cape…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• E7389 (eribulin)

Snippet

Sponsor: Eisai Inc. | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2012-05-15